Educational speaker program: Advancing the Treatment of BRAF+ Metastatic Melanoma With First-Line Combination Therapy, Everett, WA, June 14th (Non-PSONS)

Posted on 24. May, 2017 by in non-PSONS

You are cordially invited to attend an educational speaker program: Advancing the Treatment of BRAF+ Metastatic Melanoma With First-Line Combination Therapy (T-MAF-1159385)

Faculty
Krista Treichel, RN, BSN, OCN
University of Colorado Hospital

Date and Time
Wednesday, June 14, 2017
6:00 PM Pacific

Program Location
Terracotta Red
2820 Hewitt Avenue
Everett, WA 98201
(425) 322-5132

Confirm Your Attendance

On behalf of Novartis Pharmaceuticals Corporation, RSVP by:
06/09/2017
Rainer Harstrick
Novartis Representative
Program Host
(206) 979-6258 (Mobile)
rainer.harstrick@novartis.com

The information you submit will be used by Novartis and business partner, AHM, to register and communicate regarding this event.

Meeting Code: 17-QEDG4B-3 (16159924)

Novartis acts in accordance with the PhRMA Code on Interactions with Healthcare Professionals. The PhRMA Code states that inclusion of a health care professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high-quality learning environment for all participating health care professionals. Thank you.

Download the flyer here: Invite RSVP Host Р2017 (REF# 3293203 3459285)

Comments are closed.